All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy

Synergistic immunotherapy of immune checkpoint blockade (ICB) and immunogenic cell death (ICD) has shown remarkable therapeutic efficacy in various cancers. However, patients show low response rates and undesirable outcomes to these combination therapies owing to the recycling mechanism of programme...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Sukyung, Shim, Man Kyu, Yang, Suah, Lee, Jaewan, Yun, Wan Su, Cho, Hanhee, Moon, Yujeong, Min, Jin Young, Han, Eun Hee, Yoon, Hong Yeol, Kim, Kwangmeyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276196/
https://www.ncbi.nlm.nih.gov/pubmed/37334068
http://dx.doi.org/10.1016/j.bioactmat.2023.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276196/
https://www.ncbi.nlm.nih.gov/pubmed/37334068
http://dx.doi.org/10.1016/j.bioactmat.2023.05.016

Ejemplares similares